Nik Kolatkar, MD

Nik Kolatkar serves as Vice President of US Medical at Genentech, overseeing US data sciences, digital medical & AI, clinical operations, medical education, quality & compliance, and the Foundational Products portfolio spanning 21 medicines and >$7B in annual revenue.

During his 16 years at Genentech, Nik has held multiple senior leadership roles including Global Medical Director in Basel, Switzerland following the merger of Genentech and Roche in 2010, Head of UK Medical in London, UK, and Lifecycle Leader in Global Product Strategy in South San Francsico, California.

Prior to Genentech, Nik led pivotal trials in cardiovascular and metabolism at GlaxoSmithKline R&D. He has a proven track record of novel and visionary strategies that have contributed to successful launches and new indications for many products in the Genentech portfolio. Prior to working in the biopharmaceutical industry, Nik founded a digital health startup where he raised seed capital, launched the company’s initial product, and successfully delivered a US Surgeon General initiative for the US Department of Health and Human Services.

His education includes a Bachelors’ Degree (B.A.) in Biological Sciences from Cornell University, Master of Science (M.S.) in Biophysics from Georgetown University, a Doctorate in Medicine (M.D.) from University of Minnesota Medical School, and Master of Public Health (M.P.H.) from Harvard University. Nik completed his clinical residency training at Baylor College of Medicine and subspecialty fellowship in Endocrinology and Metabolism at the Brigham and Women’s Hospital, Harvard Medical School.